Biography:
Dr. Shahawy works on at least 10 active medical research trials at any given time, and is a frequent lecturer on topics of cardiology at symposia, congresses and annual conferences on every continent. He has authored or co-authored over 200 abstracts and research papers, and published original work which was performed at the Mayo Clinic in Rochester, Minnesota on the Effect of Magnesium Deficiency and Thyroid Hormone on the Heart. He has also been leading author of recent original article published in September 15, 2017 in the American Journal of cardiology entitled efficacy and safety of Alirocumab versus ezetimibe over 2 years [ from Odyssey combo II] and co Author on related topic on March 15, 2015 in the New England Journal of Medicine entitled: Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events.
In the past few years, he has been honored with multiple awards recognizing his professional skills and accomplishments, of particular note is his receipt of the Golden Doctor Diploma from the University of Vienna Austria in June 2014. He has been included in respected lists of top doctors in America and being named to the US News list of Top Doctors from 2011-2014.along with recent recognition by the European Society of cardiology/ EuroPrevent 2017 where he was awarded the best of original scientific work in category of diabetes/lipids/obesity during the annual meeting in Malaga Spain April 2017. He graduated first in his class as Sum Cum Laude from the University of Vienna Austria, under the auspices of the President of Austria who personally bestowed the Golden Ring of Honor on he in a special ceremony (June 1962). He was the first non Austrian in the history of Vienna Medical School to achieve that honor. He subsequently underwent postgraduate training in Internal Medicine and Cardiology at the world renowned University Hospital in Vienna [Algmeines Krankehouse] from 1962-1967.
He moved 50 years ago [June 1967 ]to the U.S. He spent one year at the New York Medical Center, thereafter moved to the Mayo Clinic in Rochester, Minnesota for post graduate training in Internal Medicine and Cardiology until 1971. During his time at the Mayo Clinic he also obtained his Master's degree from the University of Minnesota on the Effect of Magnesium Deficiency on the Heart. After completion of 3 years as a fellow at the Mayo Clinic, he served as senior fellow and junior faculty member in the Division of Cardiology at the Medical College of Georgia.
In July 1973, Dr. Shahawy joined the faculty at the University of Florida in the Division of Cardiology. Dr Shahawy maintains his association with the University of Florida, where he is currently Clinical Professor in Medicine/Cardiology. He also serves as Clinical Professor at the University of South Florida. He was also the founder and first Medical Director for the Cardiovascular Disease Prevention Program at: He has been serving as the President of the Cardiovascular Center of Sarasota since 1975 and serves as the Founder and Medical Director for the Cardiovascular Health Assessment Center of Sarasota since 2008.
He is certified by the American Board of Internal Medicine, American Board of Cardiovascular Disease and the Certification Board of Cardiovascular Computed Tomography. He is also a member and fellow of numerous national and international organizations, including the American Colleges of Physicians, Cardiology, Chest Physicians, AHA European Society of Cardiology and an alumni of Vienna Medical School, Mayo Clinic and Mayo Doctor's Society. and currently serves as the President of the International Society for Cardiovascular Disease Prevention [ISCVP].